Pharmaceutical formulation
First Claim
Patent Images
1. A pharmaceutical composition for the treatment of an otic infection in an animal comprising Orbifloxacin or one of its pharmaceutically acceptable salts in an amount of about 0.1% to about 10% by weight, Posaconazole in an amount of about 0.01% to about 1% by weight, Mometasone in an amount of about 0.01% to about 1% by weight, a viscocity enhancing agent in an amount of about 0.1% to about 5% by weight, and at least one pharmaceutically acceptable carrier, wherein said composition is a suspension.
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate.
-
Citations
4 Claims
- 1. A pharmaceutical composition for the treatment of an otic infection in an animal comprising Orbifloxacin or one of its pharmaceutically acceptable salts in an amount of about 0.1% to about 10% by weight, Posaconazole in an amount of about 0.01% to about 1% by weight, Mometasone in an amount of about 0.01% to about 1% by weight, a viscocity enhancing agent in an amount of about 0.1% to about 5% by weight, and at least one pharmaceutically acceptable carrier, wherein said composition is a suspension.
Specification